New from #wellcometrust https://t.co/3Z2xDCLqXm Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models
Evaluation of anti insulin receptor antibodies as potential novel therapies for human insulin receptoropathy published as: https://t.co/pR4E0Wmpvu #Diabetologia #biorxiv
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
https://t.co/JdrYoVEHMg Insulin receptor activating antibodies for treating insulin receptorpathies. @DiabetologiaJnl
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
RT @DUK_research: Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemp…
Great to see Diabetes UK funded research on the cover of @DiabetologiaJnl – many congratulations to @GV_Brierley, @rksemple and Prof Kenneth Siddle for their work on the insulin receptor! Read the full paper here: https://t.co/I36ntcRty2 https://t.co/Ksmjt
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @SarahBone1: Congratulations @GV_Brierley https://t.co/nmCigZOP8a
Congratulations @GV_Brierley https://t.co/nmCigZOP8a
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
RT @GV_Brierley: The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover f…
The hard copy print version of our paper has been released and are excited to see that it has been chosen for the cover for this months edition of @DiabetologiaJnl @rksemple @DUK_research @DRWFDiabetes @MRL_Cam https://t.co/9ZhkZb8HV2 https://t.co/B2L7tj
RT @DiabetologiaJnl: #toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one s…
RT @DiabetologiaJnl: #toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one s…
RT @DiabetologiaJnl: #toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one s…
RT @DiabetologiaJnl: #toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one s…
RT @DiabetologiaJnl: #toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one s…
#toptweet this wk! Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after study of anti-receptor antibodies in cell culture models #SevereInsulinResistance https://t.co/rmsW3bxbET 🔓
insulin receptor antibodies as potential novel therapies #diabetes @DiabetesUK @Diabetescouk @DiabetesCanada @AmDiabetesAssn https://t.co/9FGHyBC67C
RT @POhukainen: Whoa! Wasn't aware of this mutation in the insulin receptor that causes extreme #insulinresistance and death https://t.co/S…
A cure for resistance? https://t.co/YKHAUurXR0
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
Congratulations Gemma @GV_Brierley, nice work! https://t.co/ap08poKnMO
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
Whoa! Wasn't aware of this mutation in the insulin receptor that causes extreme #insulinresistance and death https://t.co/S3sQMVkXoc
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
RT @DiabetologiaJnl: Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after st…
Possible biological therapy for extreme insulin resistance due to insulin receptor defects is one step closer after study of anti-receptor antibodies in cell culture models #SevereInsulinResistance https://t.co/rmsW3bOMwr 🔓
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
Novel therapies on the horizon for highly insulin resistant patients https://t.co/R8xhjjK3Fn
RT @GV_Brierley: Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @Dia…
Excited to see our paper is now available online! https://t.co/kiyu7lmzI4 @rksemple @mrl_cam Thanks to funding from: @DiabetesUK @DUK_research @DRWFDiabetes